Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.

作者: John D. Groopman , Denise Johnson , Thomas W. Kensler

DOI: 10.3233/CBM-2005-1103

关键词: AflatoxinAflatoxin BEpidemiologyPublic healthMedicineEnvironmental healthBiotechnologyCancerPsychological interventionCancer riskHepatitis B virus

摘要: The use of biomarkers in molecular epidemiology studies for identifying stages the progression development health effects environmental agents has potential providing important information critical regulatory, clinical and public problems. Investigations aflatoxins probably represents one most extensive data sets field this work may serve as a template future other agents. are naturally occurring mycotoxins found on foods such corn, peanuts, various nuts cottonseed they have been demonstrated to be carcinogenic many experimental models. As result nearly thirty years study, epidemiological human populations, aflatoxin B(1) was classified humans by International Agency Research Cancer. long-term goal research described herein is application preventative interventions populations at high-risk cancer. Several specific validated now being used intermediate prevention studies. these based upon knowledge biochemistry toxicology gleaned from both These subsequently utilised models provide modulation markers under different situations disease risk. This systematic approach provides encouragement preventive should development, validation chemical-specific cancer or chronic diseases.

参考文章(32)
S.-Y. Kuang, P. E. Jackson, J.-B. Wang, P.-X. Lu, A. Munoz, G.-S. Qian, T. W. Kensler, J. D. Groopman, Specific mutations of hepatitis B virus in plasma predict liver cancer development Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 3575- 3580 ,(2004) , 10.1073/PNAS.0308232100
Liang-Shang Gan, Paul L. Skipper, Xiaocong Peng, John D. Groopman, Jun-shi Chen, Gerald N. Wogan, Steven R. Tannenbaum, Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1 Carcinogenesis. ,vol. 9, pp. 1323- 1325 ,(1988) , 10.1093/CARCIN/9.7.1323
Thomas W. Kensler, John D. Groopman, Bill D. Roebuck, Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man. Mutation Research. ,vol. 402, pp. 165- 172 ,(1998) , 10.1016/S0027-5107(97)00294-7
Thomas Primiano, Jonathan A. Gastel, Thomas W. Kensler, Thomas R. Sutter, Isolation of cDNAs representing dithiolethione-responsive genes Carcinogenesis. ,vol. 17, pp. 2297- 2303 ,(1996) , 10.1093/CARCIN/17.11.2297
SHUN-ZHANG YU, Primary prevention of hepatocellular carcinoma Journal of Gastroenterology and Hepatology. ,vol. 10, pp. 674- 682 ,(1995) , 10.1111/J.1440-1746.1995.TB01370.X
Gregory D. Kirk, Anne-Marie Camus-Randon, Maimuna Mendy, James J. Goedert, Philippe Merle, Christian Trépo, Christian Bréchot, Pierre Hainaut, Ruggero Montesano, Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. Journal of the National Cancer Institute. ,vol. 92, pp. 148- 153 ,(2000) , 10.1093/JNCI/92.2.148
Peta E Jackson, Shuang-Yuan Kuang, Jin-Bing Wang, Paul T Strickland, Alvaro Muñoz, Thomas W Kensler, Geng-Sun Qian, John D Groopman, Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis. ,vol. 24, pp. 1657- 1663 ,(2003) , 10.1093/CARCIN/BGG101
William M. Lee, Hepatitis B Virus Infection New England Journal of Medicine. ,vol. 337, pp. 1733- 1745 ,(1997) , 10.1056/NEJM199712113372406
David Sidransky, MD, Monica Hollstein, Ph. D, CLINICAL IMPLICATIONS OF THE p53 GENE Annual Review of Medicine. ,vol. 47, pp. 285- 301 ,(1996) , 10.1146/ANNUREV.MED.47.1.285
Thomas W. Kensler, Bert Vogelstein, John D. Groopman, Yuan Rong Zhu, Geng Sun Qian, Marlin D. Friesen, Jin Bing Wang, Peta E. Jackson, Yiqian Wu, Peixin Lu, Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Research. ,vol. 61, pp. 33- 35 ,(2001)